← Back to directory

Felipe Prósper

Researcher Next ID · RN-034279

Researcher · Biochemistry, Genetics and Molecular Biology

Instituto de Salud Carlos III

Madrid, Sweden

Accepting doctoral researchersFunding unknown
Works count
1,030
Citation count
30,769
H-index
90
i10-index
395

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Multiple Myeloma Research and Treatments
Protein Degradation and Inhibitors
Tissue Engineering and Regenerative Medicine
Acute Myeloid Leukemia Research
Mesenchymal stem cell research

Publications

  • Lipid nanoparticles for siRNA delivery in cancer treatment

    Journal of Controlled Release · 2023 · 10.1016/j.jconrel.2023.07.054

  • Single-Cell RNA Sequencing Analysis Reveals a Crucial Role for CTHRC1 (Collagen Triple Helix Repeat Containing 1) Cardiac Fibroblasts After Myocardial Infarction

    Circulation · 2020 · 10.1161/circulationaha.119.044557

  • Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study

    EClinicalMedicine · 2020 · 10.1016/j.eclinm.2020.100454

  • Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

    Cell · 2020 · https://doi.org/10.1016/j.cell.2020.04.004

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Journal for ImmunoTherapy of Cancer · 2020 · https://doi.org/10.1136/jitc-2019-000337

  • The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma

    Clinical Cancer Research · 2019 · 10.1158/1078-0432.ccr-18-1597

  • HDAC Inhibitors in Acute Myeloid Leukemia

    Cancers · 2019 · 10.3390/cancers11111794

  • Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression

    Nature Medicine · 2019 · 10.1038/s41591-019-0499-y

  • The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia

    Nature Medicine · 2018 · 10.1038/s41591-018-0028-4

  • Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment

    Cancer Cell · 2017 · https://doi.org/10.1016/j.ccell.2017.02.002

  • Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II)

    Journal of Translational Medicine · 2016 · 10.1186/s12967-016-0998-2

  • Whole-genome fingerprint of the DNA methylome during human B cell differentiation

    Nature Genetics · 2015 · 10.1038/ng.3291

  • Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma

    New England Journal of Medicine · 2013 · https://doi.org/10.1056/nejmoa1300439

  • A DNA methylation fingerprint of 1628 human samples

    Genome Research · 2011 · https://doi.org/10.1101/gr.119867.110

  • Epigenetic Silencing of the Tumor Suppressor MicroRNA Hsa-miR-124a Regulates CDK6 Expression and Confers a Poor Prognosis in Acute Lymphoblastic Leukemia

    Cancer Research · 2009 · 10.1158/0008-5472.can-08-4025

  • Epigenetic regulation of microRNA expression in colorectal cancer

    International Journal of Cancer · 2009 · https://doi.org/10.1002/ijc.24638

  • Transplantation of Adipose Derived Stromal Cells is Associated with Functional Improvement in a Rat Model of Chronic Myocardial Infarction

    European Journal of Heart Failure · 2008 · 10.1016/j.ejheart.2008.03.017

  • Down-Regulation of hsa-miR-10a in Chronic Myeloid Leukemia CD34+ Cells Increases USF2-Mediated Cell Growth

    Molecular Cancer Research · 2008 · 10.1158/1541-7786.mcr-08-0167

  • Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study

    Blood · 2006 · https://doi.org/10.1182/blood-2006-04-019778

  • Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas

    Blood · 2006 · 10.1182/blood-2006-06-026500

  • Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia

    Oncogene · 2005 · 10.1038/sj.onc.1208866

  • Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia

    Blood · 2004 · 10.1182/blood-2004-03-0954

  • Induction of Nod2 in Myelomonocytic and Intestinal Epithelial Cells via Nuclear Factor-κB Activation

    Journal of Biological Chemistry · 2002 · https://doi.org/10.1074/jbc.m206473200

  • Blockade of the Bcr-Abl Kinase Activity Induces Apoptosis of Chronic Myelogenous Leukemia Cells by Suppressing Signal Transducer and Activator of Transcription 5–Dependent Expression of Bcl-XL

    The Journal of Experimental Medicine · 2000 · 10.1084/jem.191.6.977

  • Erythropoietin Can Induce the Expression of Bcl-xLthrough Stat5 in Erythropoietin-dependent Progenitor Cell Lines

    Journal of Biological Chemistry · 1999 · 10.1074/jbc.274.32.22165

Current projects

    No projects listed.